Sociodemographic Factors, Intent-Uptake Disparities, and Nirsevimab Availability in Infant RSV Immunoprophylaxis

Background/Objectives: Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and infant hospitalization in the US. RSV prevention evolved in 2023 as nirsevimab and maternal RSV pre-fusion vaccine became available for healthy newborns and infants. This study investigates sociode...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Brody J. Lipsett, Benjamin N. Fogel, Katherine E. Shedlock, Ian M. Paul, Eric W. Schaefer, Ruth E. Gardner, Leah D. Kaye, Steven D. Hicks
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2025-10-01
Serie:	Pediatric Reports
Soggetti:	respiratory syncytial virus immunization nirsevimab infant health socioeconomic status health disparities
Accesso online:	https://www.mdpi.com/2036-7503/17/5/109
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!